India Pharma Inc rates NaMo govt
The pharma sector gives the Narendra Modi-led Government full marks for good intentions but prefers to reserve judgement till it…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
‘100 days are too short to make a definitive assessment.’
Rating: 7/ 10 The Narendra Modi-led Government has completed over 100 days in power and there have been many speedy and sweeping…
‘We need to encourage innovation, not deter scientific & medical community’
Rating: 1/ 10 While a lot has been spoken about access to healthcare, the role of innovation in access to healthcare, especially…
‘If single-minded focus on development agenda continues, success will follow’
Rating: 4/ 5 It has been an impressive start by the Prime Minister. What is important to note is that he is very much focused on…
‘Steps in the right direction; a lot still needs to be done’
Rating: 3.5-4 / 10 Though the life sciences sector is yet to see ‘radical reforms’, the Narendra Modi Government’s efforts to…
‘We have to give time to set the wheels in motion’
Rating: 2.5/ 10 It is too early to be measure the impact that the new Government has had on the economy and markets. The Prime…
Analysing reactions to India’s draft pharma patent g’lines
Sankar Sundaram, pharmaceutical sciences professor at JSS University, Mysore and a patent agent with India's intellectual property…
Ashland Pharmaceutical Centre of Excellence conducts training programmes
Training will help the channel partners from India and other parts of Asia to understand the technology
Trapping The Ebola Virus
The Ebola outbreak has become a global emergency today. While a few drugs and vaccines are still under trial, the news of possible…
In Choppy Waters
Low investor sentiment, regulatory hurdles, drying pipelines are some of the challenges facing the biotech sector. It remains to…